Cardiovascular Disease

>

Latest News

Among Stroke Survivors, GLP-1RAs, SGLT2is May Reduce Risk of Future MI, Recurrent Stroke / image credit American Heart Association
Among Stroke Survivors, GLP-1RAs, SGLT2is May Reduce Risk of Future MI, Recurrent Stroke

November 11th 2024

AHA 2024. Study authors reported a 74% lower risk of death and an 84% lower risk of MI among participants taking either a GLP-1RA or an SGLT2i.

COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types

October 9th 2024

Progression of Subclinical Atherosclerosis Independently Predicts All-Cause Mortality / image credit - plaque: ©Tefi/stock.adobe.com
Progression of Subclinical Atherosclerosis Independently Predicts All-Cause Mortality

October 2nd 2024

Recent Recreational Drug Use Ups Risk of Repeat Serious CV Event: Daily Dose / image credit: ©New Africa/AdobeStock
Recent Recreational Drug Use Ups Risk of Repeat Serious CV Event: Daily Dose

September 18th 2024

Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose / image credit: ©New Africa/AdobeStock
Statin Plus Ezetimibe Outperforms High-Dose Statins in LDL-C Reduction: Daily Dose

September 12th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.